Jordi Serra-Musach

ORCID: 0000-0002-5754-6712
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cytokine Signaling Pathways and Interactions
  • Nuclear Receptors and Signaling
  • Cancer Mechanisms and Therapy
  • Neuroblastoma Research and Treatments
  • Neurofibromatosis and Schwannoma Cases
  • Bioinformatics and Genomic Networks
  • Melanoma and MAPK Pathways
  • Epigenetics and DNA Methylation
  • Single-cell and spatial transcriptomics
  • Computational Drug Discovery Methods
  • FOXO transcription factor regulation
  • Nerve Injury and Rehabilitation
  • Bone Metabolism and Diseases
  • NF-κB Signaling Pathways
  • T-cell and B-cell Immunology
  • RNA modifications and cancer
  • Advanced Proteomics Techniques and Applications
  • Gene Regulatory Network Analysis
  • Biotin and Related Studies
  • Cell Adhesion Molecules Research
  • Synthesis and biological activity
  • Tuberous Sclerosis Complex Research
  • Sarcoma Diagnosis and Treatment
  • Genetic Associations and Epidemiology
  • Estrogen and related hormone effects

Institut d'Investigació Biomédica de Bellvitge
2010-2023

Institut Català d'Oncologia
2010-2022

Linköping University
2016-2020

Bellvitge University Hospital
2015-2016

Institut d'Investigació Biomèdica de Girona
2012-2013

European Bioinformatics Institute
2013

European Molecular Biology Laboratory
2013

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
2012

DNA methylation is the most studied epigenetic mark and CpG central to many biological processes human diseases. Since cancer has highlighted contribution disease of aberrant patterns, such as presence promoter island hypermethylation-associated silencing tumor suppressor genes global hypomethylation defects, their importance will surely become apparent in other pathologies. However, advances obtaining comprehensive methylomes are hampered by high cost time-consuming aspects single...

10.4161/epi.6.6.16196 article EN Epigenetics 2011-06-01

Human aging cannot be fully understood in terms of the constrained genetic setting. Epigenetic drift is an alternative means explaining age-associated alterations. To address this issue, we performed whole-genome bisulfite sequencing (WGBS) newborn and centenarian genomes. The DNA had a lower methylation content reduced correlation status neighboring cytosine--phosphate--guanine (CpGs) throughout genome comparison with more homogeneously methylated DNA. hypomethylated CpGs observed compared...

10.1073/pnas.1120658109 article EN Proceedings of the National Academy of Sciences 2012-06-11
Christopher A. Maxwell Javier Benítez Laia Gómez‐Baldó Ana Osório Núria Bonifaci and 95 more Ricardo Fernández‐Ramires Sylvain V. Costes Elisabet Guinó Helen Chen Gareth J. R. Evans Pooja Mohan Isabel Català Anna Petit Helena Aguilar Alberto Villanueva Àlvaro Aytés Jordi Serra-Musach Gad Rennert Flavio Lejbkowicz Paolo Peterlongo Siranoush Manoukian Bernard Peissel Carla B. Ripamonti Bernardo Bonanni Alessandra Viel Anna Allavena Loris Bernard Paolo Radice Eitan Friedman Bella Kaufman Yael Laitman Maya Dubrovsky Roni Milgrom Anna Jakubowska Cezary Cybulski Bohdan Górski Katarzyna Jaworska Katarzyna Durda Grzegorz Sukiennicki Jan Lubiński Yin Yao Shugart Susan M. Domchek Richard Letrero Barbara L. Weber Frans B.L. Hogervorst Matti A. Rookus J. Margriet Collée Peter Devilee Marjolijn J. L. Ligtenberg Rob B. van der Luijt Cora M. Aalfs Quinten Waisfisz Juul Wijnen C. E. P. van Roozendaal Douglas F. Easton Susan Peock Margaret Cook Clare Oliver Debra Frost Patricia Harrington D. Gareth Evans Fiona Lalloo Rosalind A. Eeles Louise Izatt Carol Chu Diana Eccles Fiona Douglas Carole Brewer Heli Nevanlinna Tuomas Heikkinen Fergus J. Couch Noralane M. Lindor Xianshu Wang Andrew K. Godwin Maria A. Caligo Grazia Lombardi Niklas Loman Per Karlsson Hans Ehrencrona Anna von Wachenfeldt Rósa B. Barkardóttir Ute Hamann Muhammad Usman Rashid Adriana Lasa Miguel de la Hoya Raquel Andrés Michael Schmitt Volker Assmann Kristen N. Stevens Kenneth Offit João Curado Hagen Tilgner Roderic Guigó Gemma Aiza Joan Brunet Joan Castellsagué Griselda Martrat Ander Urruticoechea Ignacio Blanco Laima Tihomirova

Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization is an early hallmark breast carcinogenesis. In BRCA1 mutation carriers, accumulation stem progenitor cells in normal increased risk developing tumors basal-like type suggest that regulates stem/progenitor cell proliferation differentiation. However, the function this process its link to carcinogenesis remain unknown. Here we depict a molecular mechanism involving RHAMM polarity and, when perturbed,...

10.1371/journal.pbio.1001199 article EN cc-by PLoS Biology 2011-11-15

Abstract Motivation: Web interfaces provide access to numerous biological databases. Many can be accessed in a programmatic way thanks Services. Building applications that combine several of them would benefit from single framework. Results: BioServices is comprehensive Python framework provides major bioinformatics Services (e.g. KEGG, UniProt, BioModels, ChEMBLdb). Wrapping additional based either on Representational State Transfer or Simple Object Access Protocol/Web Description Language...

10.1093/bioinformatics/btt547 article EN cc-by Bioinformatics 2013-09-23

// Marta Hergueta-Redondo 1 , David Sarrio Ángela Molina-Crespo Rocío Vicario 2 Cristina Bernadó-Morales Lidia Martínez Alejandro Rojo-Sebastián 3 Jordi Serra-Musach 4 Alba Mota 1, 5 Ángel Martínez-Ramírez 6 Maria Ángeles Castilla 7 Antonio González-Martin 8 Sonia Pernas Amparo Cano Javier Cortes 9, 10 Paolo G. Nuciforo 11 Vicente Peg 12 José Palacios 7, 13 Miguel Pujana Joaquín Arribas 2, Gema Moreno-Bueno...

10.18632/oncotarget.10787 article EN Oncotarget 2016-07-22

Genomic medicine has paved the way for identifying biomarkers and therapeutically actionable targets complex diseases, but is complicated by involvement of thousands variably expressed genes across multiple cell types. Single-cell RNA-sequencing study (scRNA-seq) allows characterization such changes in whole organs. The based on applying network tools to organize analyze scRNA-seq data from a mouse model arthritis human rheumatoid arthritis, order find diagnostic therapeutic targets....

10.1186/s13073-019-0657-3 article EN cc-by Genome Medicine 2019-07-29

Early regulators of disease may increase understanding mechanisms and serve as markers for presymptomatic diagnosis treatment. However, early are difficult to identify because patients generally present after they symptomatic. We hypothesized that T cell-associated diseases could be found by identifying upstream transcription factors (TFs) in cell differentiation prioritizing hub TFs were enriched disease-associated polymorphisms. A gene regulatory network (GRN) was constructed time series...

10.1126/scitranslmed.aad2722 article EN Science Translational Medicine 2015-11-11

RANK expression is associated with poor prognosis in breast cancer even though its therapeutic potential remains unknown. RANKL and receptor are downstream effectors of the progesterone signaling pathway. However, enriched hormone negative adenocarcinomas, suggesting additional roles for beyond hormone-dependent function. Here, to explore role once tumors have developed, we use mouse mammary tumor virus-Polyoma Middle T (MMTV-PyMT), which mimics patterns seen human adenocarcinomas....

10.1158/0008-5472.can-15-2745 article EN Cancer Research 2016-08-02

Abstract The generation of B cells is a complex process requiring several cellular transitions, including cell commitment and differentiation. Proper transcriptional control to establish the genetic programs characteristic each stage essential for correct development lymphocytes. Deregulation these particular may result in block B-cell maturation, contributing hematological malignancies such as leukemia lymphoma. However, very little currently known about role repressors normal aberrant...

10.1038/cddis.2014.594 article EN cc-by Cell Death and Disease 2015-02-12

Abstract Introduction Endocrine therapies targeting cell proliferation and survival mediated by estrogen receptor α (ERα) are among the most effective systemic treatments for ERα-positive breast cancer. However, tumors initially responsive to these acquire resistance through mechanisms that involve ERα transcriptional regulatory plasticity. Herein we identify VAV3 as a critical component in this process. Methods A cell-based chemical compound screen was carried out therapeutic strategies...

10.1186/bcr3664 article EN cc-by Breast Cancer Research 2014-05-28

Glioblastoma (GBM) still remains an incurable disease being radiotherapy (RT) the mainstay treatment. intra-tumoral heterogeneity and Glioblastoma-Initiating Cells (GICs) challenge design of effective therapies. We investigated GICs non-GICs response to RT in a paired in-vitro model addressed molecular programs activated after RT. Established heterogeneously expressed several markers displayed mesenchymal signature. Upon fractionated RT, reported higher radioresistance compared showed lower...

10.18632/oncotarget.18363 article EN Oncotarget 2017-06-03
Francesca Mateo Enrique J. Arenas H. Aguilar Jordi Serra-Musach Gorka Ruíz de Garibay and 88 more Jacopo Boni Miren Maicas Shisuo Du Francesco Iorio Carmen Herranz Abul Bashar Mir Md. Khademul Islam X Prado Alicia Llorente Lope Ana Petit August Vidal I. Català T Soler G Venturas Alejandro Rojo‐Sebastián Helena Serra Daniel Cuadras Ignacio Blanco José Lozano Françesc Canals Anieta M. Sieuwerts Vanja de Weerd Maxime P. Look Sara Puertas N. García Archibald S. Perkins Núria Bonifaci Margaretha A. Skowron Laia Gómez‐Baldó Vanessa Hernández Antonio Martínez-Aranda María Martínez‐Iniesta Xènia Serrat Julián Cerón Joan Brunet M P Barretina Miguel Ángel Cobos Gil Catalina Falo Adela Fernández Idoia Morilla Sònia Pernas M.J. Plà Xavier Andreu Miguel Ángel Seguí R. Ballester E. Castellà Mark Nellist Serafín Morales Joan Valls Ana Velasco Xavier Matías‐Guiu António Figueras José V. Sánchez‐Mut Montse Sánchez‐Céspedes Álex Cordero Jorge Gómez‐Miragaya Luís Palomero Antonio Gómez Thomas F. Gajewski Ezra E.W. Cohen M Jesiotr Lubomir Bodnar Miguel Quintela‐Fandino Núria López-Bigas Rafael Valdés‐Mas Xosé S. Puente Francesc Viñals Oriol Casanovas Mariona Graupera Javier Hernández‐Losa Santiago Ramón y Cajal Luz García‐Alonso Julio Sáez-Rodríguez Manel Esteller Àngels Sierra Natalia Martín-Martín Ander Matheu Arkaitz Carracedo Eva González‐Suárez Meera Nanjundan Javier Cortés Conxi Lázaro María D. Odero John W.M. Martens Gema Moreno‐Bueno Mary Helen Barcellos‐Hoff Alberto Villanueva Roger R. Gomis Miguel Ángel Pujana

Inhibitors of the mechanistic target rapamycin (mTOR) are currently used to treat advanced metastatic breast cancer. However, whether an aggressive phenotype is sustained through adaptation or resistance mTOR inhibition remains unknown. Here, complementary studies in human tumors, cancer models and cell lines reveal transcriptional reprogramming that supports metastasis response inhibition. This feature driven by EVI1 SOX9. functionally cooperates with positively regulates SOX9, promotes...

10.1038/onc.2016.427 article EN cc-by-nc-nd Oncogene 2016-12-19

Translational research typically aims to identify and functionally validate individual, disease-specific genes. However, reaching this aim is complicated by the involvement of thousands genes in common diseases, that many those are pleiotropic, is, shared several diseases.We integrated genomic meta-analyses with prospective clinical studies systematically investigate pathogenic, diagnostic therapeutic roles pleiotropic In a novel approach, we first used pathway analysis all published...

10.1186/gm534 article EN cc-by Genome Medicine 2014-01-01

Multimorbidity is an emerging topic in public health policy because of its increasing prevalence and socio-economic impact. However, the age- gender-dependent trends disease associations at fine resolution, underlying genetic factors, remain incompletely understood. Here, by analyzing networks from electronic medical records primary care, we identify key conditions shared factors influencing multimorbidity. Three types diseases are outlined: "central", which include chronic non-chronic...

10.1038/s41598-018-34361-3 article EN cc-by Scientific Reports 2018-10-23

Rett syndrome (RTT) is a severe neurodevelopmental disease caused almost exclusively by mutations to the MeCP2 gene. This may be regarded as synaptopathy, with impairments affecting synaptic plasticity, inhibitory and excitatory transmission network excitability. The complete understanding of mechanisms behind how transcription factor so profoundly affects mammalian brain are yet determined. What known, that involvement in activity-dependent expression programs critical link between this...

10.3390/ijms24021453 article EN International Journal of Molecular Sciences 2023-01-11

Prolactin and progesterone both orchestrate the proliferation differentiation of mammary gland during gestation. Differentiation milk secreting alveoli depends on presence prolactin receptor, downstream Jak2-Stat5 pathway transcription factor Elf5. A strict regulation Rank signaling is essential for in particular alveolar commitment. Impaired alveologenesis lactation failure are observed both, knockout overexpressing mice; however, underlying molecular mechanism responsible these phenotypes...

10.1002/stem.2271 article EN Stem Cells 2015-12-23

Lymphangioleiomyomatosis (LAM) is a rare lung-metastasizing neoplasm caused by the proliferation of smooth muscle-like cells that commonly carry loss-of-function mutations in either tuberous sclerosis complex 1 or 2 (TSC1 TSC2) genes. While allosteric inhibition mechanistic target rapamycin (mTOR) has shown substantial clinical benefit, complementary therapies are required to improve response and/or treat specific patients. However, there lack LAM biomarkers could potentially be used monitor...

10.1371/journal.pone.0132546 article EN cc-by PLoS ONE 2015-07-13

Understanding the mechanisms of cancer therapeutic resistance is fundamental to improving care. There clear benefit from chemotherapy in different breast settings; however, knowledge mutations and genes that mediate incomplete. In this study, by modeling chemoresistance patient-derived xenografts (PDXs), we show adaptation therapy genetically complex identify loss transcription factor 4 (TCF4) associated with process. A triple-negative BRCA1-mutated PDX was used study genetics...

10.1242/dmm.032292 article EN cc-by Disease Models & Mechanisms 2018-01-01

Cancer patients often show no or only modest benefit from a given therapy. This major problem in oncology is generally attributed to the lack of specific predictive biomarkers, yet global measure cancer cell activity may support comprehensive mechanistic understanding therapy efficacy. We reasoned that network analysis omic data could help achieve this goal. A "cancer activity" (CNA) was implemented based on previously defined feature communicability. The nodes and edges corresponded human...

10.1186/s13073-016-0340-x article EN cc-by Genome Medicine 2016-08-24

Malignant peripheral nerve sheath tumors (MPNST) are soft-tissue sarcomas that the leading cause of mortality in patients with Neurofibromatosis type 1 (NF1). Single chemotherapeutic agents have shown response rates ranging from 18% to 44% clinical trials, so there is still a high medical need identify combination treatments improve prognosis and outcome. We screened collection compounds NCATS Mechanism Interrogation PlatE (MIPE) library three MPNST cell lines, using viability apoptosis...

10.1158/1535-7163.mct-21-0947 article EN Molecular Cancer Therapeutics 2022-05-05

Journal Article Cancer develops, progresses and responds to therapies through restricted perturbation of the protein#x2013;protein interaction network Get access Jordi Serra-Musach, Serra-Musach Translational Research Laboratory, Breast Unit, Catalan Institute Oncology (ICO), Bellvitge for Biomedical (IDIBELL), Gran via 199, L'Hospitalet del Llobregat, Barcelona 08908, Catalonia, SpainICO, IdIBGi, Girona 17007, Spain Search other works by this author on: Oxford Academic Google Scholar Helena...

10.1039/c2ib20052j article EN Integrative Biology 2012-01-01

Specific immunotherapy (SIT) reverses the symptoms of seasonal allergic rhinitis (SAR) in most patients. Recent studies report type I interferons shifting balance between T helper cell (Th1) and II cells (Th2) towards Th2 dominance by inhibiting differentiation naive into Th1 cells. As SIT is thought to cause a shift dominance, we hypothesized that would alter interferon signaling. To test this, allergen diluent challenged CD4 + from healthy controls patients different time points were...

10.1155/2016/5153184 article EN cc-by Journal of Immunology Research 2016-01-01
Coming Soon ...